Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.57 |
| ▸ | CES1 | P23141 | 8/20 | 0.57 |
| ▸ | CES2 | O00748 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2927729 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL380746 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2934619 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL9449697 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL4156201 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2128149 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2935238 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2926268 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2935093 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL145805 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003353-A1 | BROMOCRIPTINE FOR USE IN TREATING EYE DISEASES ASSOCIATED WITH ELEVATED LEVEL OF VEGF AND A PHARMACEUTICAL COMPOSITION COMPRISING BROMOCRIPTINE | Oseka, Maciej (PL) | 2022-06-01 | — | — | EP | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260022384-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2026-01-22 | — | — | US | disclosed |
| US-12491217-B2 | Compositions and methods for promoting healthy neural development in an unborn baby | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-09 | — | — | US | disclosed |
| US-20240180976-A1 | MICROBIAL CONSORTIUM AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-06-06 | — | — | US | disclosed |
| EP-4249053-A2 | MICROBIAL CONSORTIUM AND USES THEREOF | The Regents of The University of California (US) | 2023-09-27 | — | — | EP | disclosed |
| CN-116685305-A | Cleaning composition | 日本乐敦制药株式会社 | 2023-09-01 | — | — | CN | disclosed |
| US-20230181621-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2023-06-15 | — | — | US | disclosed |
| CN-115137722-A | Composition for anti-aging | 株式会社明治 | 2022-10-04 | — | — | CN | disclosed |
| US-20220233611-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-28 | — | — | US | disclosed |
| US-20200284805-A1 | BIOMARKERS RELATED TO ORGAN FUNCTION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3681521-A1 | METABOLOMIC REVISION OF MAMMALIAN INFANTS | Evolve Biosystems Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| US-10668118-B2 | Microbial consortium and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-06-02 | — | — | US | disclosed |
| US-20200121742-A1 | COMPOSITIONS FOR TREATING INFLAMMATION AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-04-23 | — | — | US | disclosed |
| WO-2019055718-A1 | METABOLOMIC REVISION OF MAMMALIAN INFANTS | Evolve Biosystems, Inc. (US) | 2019-03-21 | — | — | WO | disclosed |
| US-20180264053-A1 | MICROBIAL CONSORTIUM AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-09-20 | — | — | US | disclosed |
| US-20150083146-A1 | PERSONAL VAPORIZER LIQUID FOR EMULSIFYING OIL-SOLUBLE COMPOUNDS AND RESINS | Verso PV, LLC | 2015-03-26 | — | — | US | disclosed |
| WO-2015042589-A1 | PERSONAL VAPORIZER LIQUID FOR EMULSIFYING OIL-SOLUBLE COMPOUNDS AND RESINS | Verso PV, LLC (US) | 2015-03-26 | — | — | WO | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-5443989-A | Combining dipalmitoyal phosphatidyl choline phophoglyceride present in fetus lung with phospholipase enzyme which cleaves polar group and releases dipalmatoyl glycerol; solvent extraction, chromatography to detect glycerol quantity | BETH ISRAEL HOSPITAL ASSOCIATION (US) | 1995-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181621-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | ASNS, GLS, GLS2 | FAAH 1807/4885CES1 159/4885CES2 2136/4885 |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | FAAH 384/4885CES1 2114/4885CES2 3018/4885 |
| US-20260022384-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | ASNS, AARS1, NARS1 | FAAH 2937/4885CES1 504/4885CES2 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.